Shares of Divi's Laboratories Ltd. traded 1.62 per cent down in Wednesday's trade at 01:12PM (IST). Around 125,452 shares changed hands on the counter.

The stock opened at Rs 3265.0 and touched an intraday high and low of Rs 3288.0 and Rs 3156.9, respectively, in the session so far. The stock of Divi's Laboratories Ltd. quoted a 52-week high of Rs 3388.0 and a 52-week low of Rs 1590.0.

Total market cap of the Divi's Laboratories Ltd. stood at Rs 84425.65 crore at the time of writing this report.





Key Financials
The company reported consolidated sales of Rs 1730.47 crore for the quarter ended 30-Jun-2020, up 24.52 per cent from previous quarter's Rs 1389.71 crore and up 48.81 per cent from the year-ago quarter's Rs 1162.88 crore.


The net profit for latest quarter stood at Rs 492.06 crore, up 80.61 per cent from the same quarter a year ago.


Shareholding pattern
As of 30-Jun-2020, domestic institutional investors held 15.57 per cent stake in the firm, while foreign institutional investors held 18.17 per cent and the promoters 51.97 per cent.

Valuation ratio
According to BSE data, the stock traded at a P/E multiple of 52.89 and a price-to-book ratio of 7.22. A higher P/E ratio shows investors are willing to pay a higher price because of better future growth expectations.Price-to-book value indicates the inherent value of a company and is the measure of the price that investors are ready to pay even for no growth in the business.

Divi's Laboratories Ltd. belongs to the Pharma - Indian industry.